Literature DB >> 10580966

Transjugular intrahepatic portosystemic shunts formed with polyethylene terephthalate-covered stents: experimental evaluation in pigs.

Z J Haskal1, L H Brennecke.   

Abstract

PURPOSE: To evaluate the safety, efficacy, and tissue response associated with Wallstents covered with polyethylene terephthalate (PETP) compared with those associated with uncovered Wallstents for creation of transjugular intrahepatic portosystemic shunts (TIPS) in a porcine model.
MATERIALS AND METHODS: Thirteen TIPS were created in 13 minipigs: eight with PETP-covered Wallstents, five with standard Wallstents. Shunt venography was performed at 5-8 weeks, and necropsy was performed at 7-8 weeks. Histopathologic, immunohistochemical, and scanning electron microscopic examinations were performed.
RESULTS: Mean shunt stenoses of the control and graft groups were 45% and 53%, respectively. Graft stenoses involved the entire graft-bearing segment, whereas bare stent stenoses were localized within the liver tract. Myofibroblast and extracellular collagen matrix proliferation encompassed both control and graft-covered stents. There was one graft TIPS occlusion. One control TIPS stenosis was due to transstent proliferation of normal porcine hepatic tissue. A small focus of bile staining was seen on the abluminal surface of one TIPS, which was a patent PETP-lined shunt.
CONCLUSION: PETP graft TIPS provided equal, but not superior, patency to that of bare stent TIPS. The pattern of PETP TIPS graft healing differed from that of bare stents but was similar to that reported with other polyester graft vascular implants and consisted of diffuse transmural penetration and paving of the graft surface by extracellular collagen matrix and myofibroblasts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10580966     DOI: 10.1148/radiology.213.3.r99dc24853

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.

Authors:  David C Madoff; Michael J Wallace
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

2.  Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts?

Authors:  Manfred Cejna
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

3.  Covered stents in transjugular portosystemic shunt: healing response to non-porous ePTFE covered stent grafts with and without intraluminal irradiation.

Authors:  Klaus A Hausegger; Horst Portugaller; Nicolas P Macri; Josef Tauss; Peter Schedlbauer; Johannes Deutschmann; Georg Stücklschweiger; Heidi Stranzl
Journal:  Eur Radiol       Date:  2002-10-31       Impact factor: 5.315

4.  Correspondence re: recanalization of an occluded intrahepatic portosystemic covered stent via the percutaneous transhepatic approach.

Authors:  Ziv J Haskal
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

5.  Efficacy of a dexamethasone-eluting nitinol stent on the inhibition of pseudo-intimal hyperplasia in a transjugular intrahepatic portosystemic shunt: an experimental study in a swine model.

Authors:  Tae Seok Seo; Joo Hyeong Oh; Young Koo Park; Ho Young Song; Sang Joon Park; Sun Hong Yuk
Journal:  Korean J Radiol       Date:  2005 Oct-Dec       Impact factor: 3.500

6.  MRI-monitored intra-shunt local agent delivery of motexafin gadolinium: towards improving long-term patency of TIPS.

Authors:  Han Wang; Feng Zhang; Yanfeng Meng; Tong Zhang; Patrick Willis; Thomas Le; Stephanie Soriano; Erik Ray; Karim Valji; Guixiang Zhang; Xiaoming Yang
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 7.  The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.

Authors:  Fabrizio Fanelli
Journal:  ISRN Hepatol       Date:  2014-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.